Atlas Trials

Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma

Clinical trial NCT02124226 · UNKNOWN

Trial details

NCT number
NCT02124226
Sponsor
University of Catania
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Low Dose Methotrexate in Severe Chronic Asthma
Start date
2021-12-01
Primary completion
2022-04-01
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.